YUYAO BIOTECH
Yuyao Biotech is a biotechnology company focusing on major unmet clinical drug needs, led by artificial intelligence and modern drug creation technology. They treat hematological tumors, neurodegenerative diseases, and autoimmune diseases. They focus on innovation to benefit human health.
YUYAO BIOTECH
Industry:
Biopharma Biotechnology Medical
Founded:
2020-04-13
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.yuyaobiotech.com
Total Employee:
51+
Status:
Active
Contact:
021-6402-5882
Email Addresses:
[email protected]
Total Funding:
90 M CNY
Technology used in webpage:
Euro Pound Sterling Japanese Yen Chinese Server Location Baidu Maps
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Enterin
Philadelphia-based biotechnology company .
Hua Medicine
Hua Medicine is a clinical-stage, innovative drug development company in China.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Tanyuan Tech
Tanyuan Technology is a thermal management solution research and development company.
Investors List
LC Ventures
LC Ventures investment in Seed Round - Yuyao Biotech
Mingyu Capital
Mingyu Capital investment in Seed Round - Yuyao Biotech
Intertek Industries
Intertek Industries investment in Seed Round - Yuyao Biotech
Official Site Inspections
http://www.yuyaobiotech.com Semrush global rank: 8.6 M Semrush visits lastest month: 502
Unable to get host informations!!!
More informations about "Yuyao Biotech"
Yuyao Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 021-6402-5882 Yuyao Biotech is a biotechnology company focusing on major unmet clinical drug needs, led by artificial intelligence and modern drug creation technology.See details»
Yuyao Biotech Company Profile 2024: Valuation, …
Yuyao Biotech General Information Description. Developer of new drugs designed for tumors, neurodegenerative diseases, autoimmune diseases and other diseases. The company focuses on small molecule drug discovery with …See details»
Yuyao Biotech - Products, Competitors, Financials, Employees ...
Yuyao Biotech. Frequently Asked Questions (FAQ). When was Yuyao Biotech founded? Yuyao Biotech was founded in 2020. Where is Yuyao Biotech's headquarters? Yuyao Biotech's …See details»
Yuyao Biotech - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 30, 2022: Seed Round - …See details»
Shanghai Yuyao Biotech - VentureRadar
Website: http://www.yuyaobiotech.com. Provides technology services and consulting, utilizing AI and modern drug creation to address clinical needs, enhancing health ...See details»
超级分子胶解难成药靶点困局，这家药企已布局10余个“First-in-Clas…
Jun 1, 2023 近日，一家ai引领、聚焦新靶点和新技术的创新小分子药物企业——上海宇耀生物科技有限公司（以下简称宇耀生物）宣布，其自主研发的stat3双磷酸化位点小分子抑制剂yy201 …See details»
Shanghai Yuyao Biotechnology Co., Ltd. - Drug pipelines, Patents ...
Explore Shanghai Yuyao Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 2 literature.See details»
宇耀生物-动脉网 - vbdata.cn
Apr 13, 2020 上海宇耀生物科技有限公司成立于2020年，是一家以人工智能和现代新药技术引领小分子药物发现，聚焦临床重大未被满足疾病，造福人类健康为使命的高新科技企业。自成立 …See details»
Shanghai Yuyao Biotechnology Co Ltd. - synapse.zhihuiya.com
了解Shanghai Yuyao Biotechnology Co Ltd. (毓鹞生物科技（上海）有限公司)公司的药物管线，治疗领域，技术平台，以及它的。See details»
宇耀生物 | 项目信息-36氪
上海宇耀生物科技有限公司由中美科学家创建成立，是一家聚焦重大未被满足临床药物需求，以人工智能和现代新药创制技术引领的，以造福全人类健康为使命的生物科技公司。宇耀生物聚焦 …See details»
宇耀生物-上海宇耀生物科技有限公司-企业详情-InvestGO数据库-By…
查看医药魔方InvestGO®数据库宇耀生物的公司信息。宇耀生物（上海宇耀生物科技有限公司），公司简介：上海宇耀生物科技有限公司致力于将AI技术与传统药物发现相结合，针 …See details»
Medicilon Interview with Dr. Wenbo Zhou | Focusing on difficult-to …
Medicilon conducted an exclusive interview with Dr. Wenbo Zhou, the founder of Yuyao Biotech. The clinical trial of YY201, the world's first STAT3 small molecule inhibitor by Yuyao Biotech, …See details»
Shanghai Yuyao Biotech - VentureRadar
Shanghai Yuyao Biotechnology Co., Ltd. was established in April 13, 2020, Their main business includes technology services, technology consulting,... ... Find out ...See details»
Shanghai Yuyao Biotechnology Co., Ltd. - synapse.zhihuiya.com
了解Shanghai Yuyao Biotechnology Co., Ltd. (上海宇耀生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 27篇新闻，疾病领域:肿瘤，内分泌与代谢疾病，血 …See details»
Yuyao Biotech Asset Profile - Preqin
Www.yuyaobiotech.com Verticals Artificial Intelligence, Big Data, Cloud Computing Company Stage Early Stage Total Amount Raised Subscriber access only Time to go Pro Get Preqin …See details»
Yuyao Biotech Stock Price, Funding, Valuation, Revenue
See Yuyao Biotech funding rounds, investors, investments, exits and more. Evaluate their financials based on Yuyao Biotech's post-money valuation and revenue.See details»
YU YAO BIOTECHNOLOGY LIMITED Company Profile - Dun
YU YAO BIOTECHNOLOGY LIMITED Company Profile | Kaohsiung City, Taiwan | Competitors, Financials & Contacts - Dun & BradstreetSee details»
Yuyao Biotech has 1 Funding Round totaling CN¥90M - Crunchbase
Funding Round search resultsSee details»
Seed Round - Yuyao Biotech - 2022-12-30 - Crunchbase
Dec 30, 2022 Yuyao Biotech raised $13046693 on 2022-12-30 in Seed Round. Start Free TrialSee details»
宇耀生物：首个创新药YY001临床（IND）获批，新一代EP4受体小 …
Mar 7, 2022 声明：因水平有限，错误不可避免，或有些信息非最及时，欢迎留言指出。本文仅作 医疗健康 相关药物介绍，非治疗方案推荐（若涉及）;本文不构成任何投资建议。2022年3月3 …See details»